SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,141.26 1,839.86
( 2.38%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

BSE 500 Dividend Leaders 50

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1208

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.85

EPS(TTM)

Face Value()

Div & Yield %

100

2.74

Back

RPG Life Sciences consolidated net profit declines 27.82% in the September 2026 quarter

Oct 30,2026

Net profit of RPG Life Sciences declined 27.82% to Rs 26.60 crore in the quarter ended September 2026 as against Rs 36.85 crore during the previous quarter ended September 2025. Sales rose 16.49% to Rs 211.64 crore in the quarter ended September 2026 as against Rs 181.68 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	211.64	181.68	16
OPM %	19.10	21.48	-
PBDT	43.84	43.45	1
PBT	37.04	38.23	-3
NP	26.60	36.85	-28

79,141.26 1,839.86 ( 2.38%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)